There is decreased risk for MACE and all-cause mortality in dialysis-dependent patients with ASCVD who are treated with statins.

(HealthDay News) — Metformin use is associated with lower risks for dementia and all-cause mortality across body mass index (BMI) groups in patients with overweight or obesity, according to a study ...

(HealthDay News) — In 2024, 26.5 percent of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables, according to an August data brief published by the ...

The U.S. Centers for Disease Control and Prevention (CDC) reported that wastewater activity for COVID-19 has climbed to a “moderate” level nationwide, up from “low” the week before.

Age and hematologic disease length are positive predictors for CKD; acute lymphoblastic leukemia is a negative predictive factor.

The FDA has approved an expanded indication of the IV formulation of Avtozma to include the treatment of CRS in patients 2 years of age and older.

(HealthDay News) — Many individuals who are not up to date with recommended vaccinations would accept vaccines if offered during an emergency department visit, according to research published in the ...

The ArteraAI Prostate Test is intended to assist clinicians and patients with risk-based decisions in localized prostate cancer.

(HealthDay News) — Most individuals living in underserved communities believe that dermatologic side effects (DSEs) from anticancer therapies (ACTs) occur at high rates, according to a study published ...

GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.

This is the first randomized trial to investigate metastasis-directed therapy plus continuous androgen deprivation therapy for oligometastatic prostate cancer.

Magnetic stimulation plus bladder training and TTNS plus bladder training are both more effective than bladder training alone.